Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Recommendations for the medical treatment of rheumatoid arthritis].
Díaz-Jouanen E, Abud-Mendoza C, Garza-Elizondo MA, Medrano-Ramírez G, Orozco-Alcalá JJ, Pacheco-Tena CF, Pineda-Villaseñor C, Pozos-Espíndola JC, Ramos-Niembro F, Román MR, Santana-Sahagún EJ. Díaz-Jouanen E, et al. Among authors: orozco alcala jj. Rev Invest Clin. 2005 Sep-Oct;57(5):735-55. Rev Invest Clin. 2005. PMID: 16419469 Review. Spanish. No abstract available.
[Guidelines in RA treatment: concepts on safety and recommendations using anti-TNF-alpha inhibitors. Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE)].
Díaz-Jouanen E, Abud-Mendoza C, Garza-Elizondo MA, Medrano-Ramírez G, Burgos-Vargas R, Orozco-Alcalá JJ, Pacheco-Tena CF, Pineda C, Pozos-Espíndola JC, Ramos-Niembro F, Robles-San-Román M, Santana-Sahagún JE; Grupo de Estudio de Nuevas Terapias de Enfermedades reumáticas (GENTE). Díaz-Jouanen E, et al. Among authors: orozco alcala jj. Rev Invest Clin. 2009 May-Jun;61(3):252-66. Rev Invest Clin. 2009. PMID: 19736814 Review. Spanish.
Evaluation of lipid profile, macular toxicity and clinical manifestations according to APO E genotype in systemic lupus erythematosus and rheumatoid arthritis patients treated with chloroquine.
Vázquez-Del Mercado M, Muñoz-Valle JF, Santos A, Bernard-Medina AG, Martínez-Bonilla G, Paczka JA, Ruiz-García H, Orozco-Alcalá J, Orozco-Barocio G, Quezada-Arellano D, Gurrola-Díaz C, Nuño-González P, Best-Aguilera CR, Chávez-Castellanos R, Panduro A. Vázquez-Del Mercado M, et al. Scand J Rheumatol. 2002;31(1):32-7. doi: 10.1080/030097402317255345. Scand J Rheumatol. 2002. PMID: 11922198 Clinical Trial.
Equivalent responses to disease-modifying antirheumatic drugs initiated at any time during the first 15 months after symptom onset in patients with seropositive rheumatoid arthritis.
Weng HH, Ranganath VK, Khanna D, Oh M, Furst DE, Park GS, Elashoff DA, Sharp JT, Gold RH, Peter JB, Paulus HE; Western Consortium of Practicing Rheumatologists. Weng HH, et al. J Rheumatol. 2010 Mar;37(3):550-7. doi: 10.3899/jrheum.090818. Epub 2010 Jan 28. J Rheumatol. 2010. PMID: 20110517 Free PMC article.
Regular and enteric coated aspirin: a reevaluation.
Orozco-Alcala JJ, Baum J. Orozco-Alcala JJ, et al. Arthritis Rheum. 1979 Sep;22(9):1034-7. doi: 10.1002/art.1780220914. Arthritis Rheum. 1979. PMID: 475872 No abstract available.
11 results